pCPA Update as of December 31, 2017
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The December 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Five new drug products have initiated pCPA negotiations, for a total of 36 active negotiations; Eight negotiations have been completed/closed, for a total of 196 joint completed/closed negotiations; and One…
pCPA Update as of November 30, 2017
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The November 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Four new drug products have initiated pCPA negotiations, for a total of 39 active negotiations; Eleven negotiations have been completed/closed, for a total of 188 joint completed/closed negotiations; and One…
pCPA Update as of October 31, 2017
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The October 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Two new drug products have initiated pCPA negotiations, for a total of 46 active negotiations; Seven negotiations have been completed/closed, for a total of 177 joint completed/closed negotiations; and No…
Lorraine Boyle Joins MORSE Consulting as Senior Advisor
Toronto, October 16, 2017 – Sherry O’Quinn and Arvind Mani are very pleased to announce that Lorraine Boyle has joined the MORSE team as a Senior Advisor. Lorraine is a former registered nurse with over 25 years of experience in the Canadian public health care system and pharmaceutical and biotechnology industry. Her experience spans sales, marketing, market access, government relations and patient advocacy. Therapeutic areas…
BC’s First Nations Health Authority PharmaCare Transition
Executive Brief The First Nations Health Authority (FNHA), formed in 2013 in the province of British Columbia, is the first province-wide health authority of its kind in Canada. Its objective is the full transferral of programs, services, and responsibilities that were under Health Canada’s First Nations Inuit Health Branch (FNIHB) − Pacific Region’s former jurisdiction. One of the many components of the…
pCPA Update as of September 30, 2017
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The September 30, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Six new drug products have initiated pCPA negotiations, for a total of 51 active negotiations; Two negotiations have been completed/closed, for a total of 170 joint completed/closed negotiations; and One…
Introducing MORSE LINKS – A Comprehensive List of Pharmaceutical Market Access Resources
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE LINKS, a new feature on our website. MORSE LINKS provides a comprehensive list of useful web links which can allow market access professionals to easily access frequently referenced web sites. Similar to other services offered by MORSE, LINKS has a user-friendly interface with information separated into broad categories to allow…
pCPA Update as of August 31, 2017
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The August 31, 2017 update has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO since the last update are: Six new drug products have initiated pCPA negotiations, for a total of 47 active negotiations; Five negotiations have been completed, for a total of 168 joint negotiations; and One new…
Upcoming Market Access Events / Conferences – September 2017
The MORSE KEY: Upcoming Events and Conferences There are a number of conferences/events/deadlines that individuals in market access may be interested in for the upcoming month of September. For more details, please visit the MORSE Key Market Access Events page. Government/Agencies September 15 – CADTH Deadline for Comments on Therapeutic Review Framework September 18 – PMPRB HDAP Meeting September 20 –CDEC Meeting Associations…
pCPA Update as of July 31, 2017
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Update The latest update as of July 31, 2017 has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO update are as follows: Seven new drug products have initiated pCPA negotiations since the last update, for a total of 46 active negotiations Three negotiations have been completed since the last update,…
Biosimilar Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada
Biosimilar Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held the Market Access 201 conference in Toronto. The theme for this conference was “Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada” which consisted of five fascinating panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming weeks, MORSE…
pCPA Update as of June 30, 2017
pan-Canadian Pharmaceutical Alliance (pCPA): Negotiation Status Updates The latest update as of June 30, 2017 has been issued by the pan-Canadian Pharmaceutical Alliance Office (pCPAO). The key highlights from the pCPAO update are as follows: Six new drug products have initiated pCPA negotiations since the last update, for a total of 42 active negotiations Seven negotiations have been completed since the last update,…
Upcoming Market Access Events / Conferences – July 2017
The MORSE KEY: Upcoming Events and Conferences There a number of conferences and events that individuals in market access may be interested in for the upcoming month: Government/Agencies July 17 – Targeted CDEC Meeting July 27 – PMPRB Form 1 Due Associations July 13-14 - Next Generation Companion Diagnostics (Philadelphia, Pennsylvania) Professional Conferences July 8 - 12 – International Health Economics Association Boston…
PMPRB Panel – CAHR Market Access 201: Parallel or Intersecting Paths – Future of Public and Private Reimbursement in Canada
Topic 1: PMPRB Panel On Tuesday, June 13, 2017, the Canadian Association for Healthcare Reimbursement (CAHR) held its Market Access 201 conference in Toronto. The theme for this conference was Parallel or Intersecting Paths, the Future of Public and Private Reimbursement in Canada which consisted of five engaging panels focusing on key topics of interest to the Canadian pharmaceutical stakeholders. Over the coming…
Introducing the MORSE WIRE – Live market access news and trends at your finger tips
Mani & O’Quinn Reimbursement Strategy Experts (MORSE) Consulting Inc. is pleased to introduce MORSE WIRE, a new feature on our website. MORSE WIRE is a newsfeed that provides real time, useful market access information to help stakeholders stay informed of the latest developments in the Canadian pharmaceutical reimbursement environment. MORSE WIRE has a user-friendly interface with 5 broad categories to allow users to sort…
Contact Us
MORSE Consulting Inc.
MORSE Consulting Inc. | Deciphering Canadian pharmaceutical market access signals to create reimbursement success.
© 2023 MORSE Consulting Inc. All rights reserved. |
Site by Directica Media
MORSE Market Access Signals - Latest in Pharmaceutical Reimbursement
